Skip to main content

Cervical Cancer Screening Lower in Rural Than Urban Health Centers

Medically reviewed by Carmen Pope, BPharm. Last updated on March 25, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, March 25, 2024 -- Up-to-date cervical cancer screening is lower in rural than urban community health centers (CHCs), with the differences mainly due to CHC-level characteristics, according to a study published online March 25 in Cancer.

Hyunjung Lee, Ph.D., from the American Cancer Society in Atlanta, and colleagues examined rural-urban differences in cervical cancer screening in CHCs and whether these differences changed during the COVID-19 pandemic using eight-year pooled Uniform Data System (2014 to 2021) data.

The researchers found that up-to-date cervical cancer screening was lower in rural than urban CHCs (38.2 versus 43.0 percent during 2014 to 2019); during the pandemic, this difference increased (43.5 versus 49.0 percent). Differences in CHC-level proportions of patients with limited English proficiency (55.9 percent) or income below the poverty level (12.3 percent) and women aged 21 to 64 years (9.8 percent), catchment area-level unemployment (3.4 percent), and primary care physician density (3.2 percent) mostly explained the rural-urban difference in screening in 2014 to 2019. The differences between rural-urban CHCs were counterbalanced by Medicaid (−48.5 percent) or no insurance (−19.6 percent). In 2020 to 2021, the contribution of these factors to rural-urban differences in cervical cancer screening generally increased.

"Tailored interventions, such as providing technical assistance and resources and language services, are needed to increase cancer screening in rural and urban CHCs, particularly cervical cancer screening in rural CHCs," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.